Rapid Response: Canada 2019 (Alzheimer’s & Related Diseases)

Deadline: 2018-12-03
Award: $200,000 CAD
Open to: Post-doctoral and above, working 30% in Canada*

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.

Encouraged are applications that bring in expertise, technologies or approaches in the following areas to advance the development of therapeutics and tools for neurodegenerative diseases of aging.

Projects must meet two conditions to be eligible:

1. Be translational research that helps accelerate the development of therapeutics for neurodegenerative diseases of aging
2. Be the development of a therapeutic, and/or tool, and/or select complementary approaches

The application process consists of two stages:
Letters of Intent (LOIs) and Proposals. To apply, applicants must submit an LOI to the Institute. Selected applicants will then be invited to submit a Proposal.